We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+23.32%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.14B
AUM Growth
-$11.8M
Cap. Flow
+$77.2M
Cap. Flow %
6.76%
Top 10 Hldgs %
64.3%
Holding
85
New
15
Increased
23
Reduced
19
Closed
17

Top Buys

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$51.9M
2
CTLT
CATALENT, INC.
CTLT
+$37.6M
3
SNY icon
Sanofi
SNY
+$26.7M
4
BIIB icon
Biogen
BIIB
+$21.8M
5
GSK icon
GSK
GSK
+$18.4M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$96.3M
2
CYH icon
Community Health Systems
CYH
+$21M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$17M
4
LNTH icon
Lantheus
LNTH
+$14.6M
5
ABMD
Abiomed Inc
ABMD
+$13M

Sector Composition

Rank Sector Weight
1 Healthcare 89.7%
2 Miscellaneous 9.48%
3 Communication Services 0.77%
4 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRX icon
51
Amneal Pharmaceuticals
AMRX
$6.11B
$1.65M 0.14%
830,960
-3,859,852
-82% -$8.65M
XOMA
52
DELISTED
Xoma
XOMA
$1.6M 0.14%
86,873
-1,529
-2% -$27.8K
RVTY icon
53
Revvity
RVTY
$14.4B
$1.57M 0.14%
11,178
+248
+2% +$33.4K
TECH icon
54
Bio-Techne
TECH
$11.3B
$1.38M 0.12%
+16,635
New +$1.32M
CYH icon
55
CALL
Community Health Systems
CYH
$413M
$1.35M 0.12%
312,900
– –
ARGX icon
56
argenx
ARGX
$64B
$1.32M 0.12%
3,476
-26
-0.7% -$9.72K
WHWK
57
Whitehawk Therapeutics
WHWK
$263M
$1.31M 0.11%
101,918
– –
HSKA
58
DELISTED
Heska Corp
HSKA
$1.21M 0.11%
19,475
+12,532
+180% +$845K
GOCO
59
DELISTED
GoHealth
GOCO
$528K 0.05%
+50,522
New +$448K
FATE icon
60
Fate Therapeutics
FATE
$291M
$440K 0.04%
43,562
-97,996
-69% -$1.84M
AFMD
61
DELISTED
Affimed
AFMD
$409K 0.04%
33,022
-155,778
-83% -$2.73M
GOSS icon
62
Gossamer Bio
GOSS
$83.2M
$335K 0.03%
154,212
-394,219
-72% -$3.25M
CBIO
63
Crescent Biopharma
CBIO
$659M
$305K 0.03%
1,006
– –
ACIU icon
64
AC Immune
ACIU
$263M
$254K 0.02%
124,589
– –
ELDN icon
65
Eledon Pharmaceuticals
ELDN
$260M
$154K 0.01%
67,743
– –
SNDA icon
66
Sonida Senior Living
SNDA
$1.8B
$147K 0.01%
11,791
– –
CTLT
67
CALL
DELISTED
CATALENT, INC.
CTLT
$90K 0.01%
+2,000
New +$109K
BOLT icon
68
Bolt Biotherapeutics
BOLT
$7.35M
$40.5K ﹤0.01%
1,559
– –
AMN icon
69
PUT
AMN Healthcare
AMN
$1.34B
– –
-19,000
Closed -$2.01M
BIIB icon
70
CALL
Biogen
BIIB
$32.3B
– –
-37,100
Closed -$9.91M
BIIB icon
71
PUT
Biogen
BIIB
$32.3B
– –
-50,000
Closed -$13.3M
ISRG icon
72
Intuitive Surgical
ISRG
$132B
– –
-9,125
Closed -$1.71M
LH icon
73
Labcorp
LH
$27.2B
– –
-8,419
Closed -$1.48M
LNTH icon
74
Lantheus
LNTH
$6.58B
– –
-206,893
Closed -$14.6M
MASS icon
75
908 Devices
MASS
$444M
– –
-130,768
Closed -$2.15M
1 2
3
4

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Eversept Partners held 85 positions worth $1.14B, down 1% from $1.15B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Eversept Partners deployed $77.2M of net new capital in Q4 2022, opening 15 new positions and adding to 23 existing holdings. Its largest new stake was CATALENT, INC.: 691,677 shares worth $31.1M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 72% a quarter earlier, followed by Miscellaneous and Communication Services.

On the sell side, the largest reduction was Community Health Systems, an estimated $21M trimmed.

  • Eversept Partners's largest Q4 2022 buy was CATALENT, INC.: 691,677 shares worth $31.1M.
  • Eversept Partners added most to Natera in Q4 2022, an estimated $51.9M increase.
  • Eversept Partners's biggest Q4 2022 reduction was Community Health Systems, cutting an estimated $21M.
  • Eversept Partners fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $96.3M.
  • Eversept Partners's ten largest holdings make up 64% of its $1.14B portfolio in Q4 2022.
  • Eversept Partners opened 15 new positions and closed 17 in Q4 2022.
  • Eversept Partners's portfolio value fell 1% quarter-over-quarter to $1.14B.

Based on Eversept Partners's 13F filing for Q4 2022, filed 14 Feb 2023.